The science behind ITV-1 hasn't changed. It was proposed for HIV exactly because it ramps up the immune response. With the overwhelming viral action of HIV simply ramping up immune response doesn't stand a chance. Which is obvious since it has no approvals anywhere.
If you can't see that ramping up the immune response in a patient with an already out of control immune response is a bad idea then common sense is not your forte. Of course maybe it's just that you are a penny stock pumper trying to dupe the gullible.
I would however suggest anyone who is thinking of investing do some due diligence on this company and it's officers. I haven't but the pattern is so obvious I don't need too.
News 
Market Data 
Discover 
